AI is being used to model gene regulation and predict cellular behavior from transcriptomic data. Learn how these tools aid ...

Editas Medicine ( EDIT 12.04%) is a promising clinical-stage company that has captured Wall Street's attention at the ...

We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...

A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and ...

Boston-based Verve is a rare example of a gene-editing company targeting a disease that affects a large population, offering ...

The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in cli ...

Synthetic chemicals and plastics are useful and indispensable in our lives. On the other hand, the world is grappling with ...

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.